Literature DB >> 9886305

A new sickle cell disease phenotype associating Hb S trait, severe pyruvate kinase deficiency (PK Conakry), and an alpha2 globin gene variant (Hb Conakry).

M Cohen-Solal1, C Préhu, H Wajcman, C Poyart, J Bardakdjian-Michau, J Kister, D Promé, C Valentin, D Bachir, F Galactéros.   

Abstract

A Guinean woman, heterozygous for haemoglobin (Hb) S, was studied because of episodes of marked anaemia, repeated typical metaphyseal painful crises and haemosiderosis. Her sickling syndrome resulted from the association of Hb S trait with a severe pyruvate kinase deficiency leading to a 2,3-DPG concentration of twice normal levels. Sequence of the PK-R gene revealed an undescribed mutation in the homozygous or hemizygous state within exon 5 (nucleotide 2670 C-->A), leading to the interchange of Ser 130 into Tyr (PK Conakry). In addition, the patient carried a new haemoglobin variant, Hb Conakry [alpha80(F1) Leu-->Val], which seemed to have a mild effect. The high intraerythrocytic 2,3-DPG concentration induced by the PK deficiency resulted in a decreased oxygen affinity which favoured sickling to a level almost similar to that of Hb S/C compound heterozygous patients. This was confirmed by oxygen binding measurements of Hb A/Hb S erythrocytes in which 2,3-DPG content was modified in vitro. Hysteresis between deoxy- and reoxygenation curves, as well as increase in the n(max) value, demonstrated that the extent of HbS polymerization in the propositus was almost the same as that of RBCs from a homozygous sickle cell patient or those of an A/S heterozygous patient with an artificial in vitro increase of 2,3-DPG concentration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9886305     DOI: 10.1046/j.1365-2141.1998.01094.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Path to facilitate the prediction of functional amino acid substitutions in red blood cell disorders--a computational approach.

Authors:  Rajith B; George Priya Doss C
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

Review 2.  Treating sickle cell disease by targeting HbS polymerization.

Authors:  William A Eaton; H Franklin Bunn
Journal:  Blood       Date:  2017-04-06       Impact factor: 22.113

3.  A review of clinical profile in sickle cell traits.

Authors:  Nitin John
Journal:  Oman Med J       Date:  2010-01

4.  Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model.

Authors:  Zenaide M N Quezado; Sayuri Kamimura; Meghann Smith; Xunde Wang; Michael R Heaven; Sirsendu Jana; Sebastian Vogel; Patricia Zerfas; Christian A Combs; Luis E F Almeida; Quan Li; Martha Quezado; Iren Horkayne-Szakaly; Penelope A Kosinski; Shaoxia Yu; Unnati Kapadnis; Charles Kung; Lenny Dang; Paul Wakim; William A Eaton; Abdu I Alayash; Swee Lay Thein
Journal:  Blood Cells Mol Dis       Date:  2022-03-12       Impact factor: 2.372

5.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Authors:  A Driss; K O Asare; J M Hibbert; B E Gee; T V Adamkiewicz; J K Stiles
Journal:  Genomics Insights       Date:  2009-07-30

6.  Prevention of hepatotoxicity due to anti tuberculosis treatment: a novel integrative approach.

Authors:  Meghna R Adhvaryu; Narsimha Reddy; Bhasker C Vakharia
Journal:  World J Gastroenterol       Date:  2008-08-14       Impact factor: 5.742

Review 7.  The carrier state for sickle cell disease is not completely harmless.

Authors:  Julia Zhe Xu; Swee Lay Thein
Journal:  Haematologica       Date:  2019-05-16       Impact factor: 9.941

Review 8.  Metabolic Reprogramming in Sickle Cell Diseases: Pathophysiology and Drug Discovery Opportunities.

Authors:  Dina Alramadhani; Anfal S Aljahdali; Osheiza Abdulmalik; B Daniel Pierce; Martin K Safo
Journal:  Int J Mol Sci       Date:  2022-07-04       Impact factor: 6.208

Review 9.  Molecular heterogeneity of pyruvate kinase deficiency.

Authors:  Paola Bianchi; Elisa Fermo
Journal:  Haematologica       Date:  2020-09-01       Impact factor: 9.941

10.  Genetic variants of PKLR are associated with acute pain in sickle cell disease.

Authors:  Xunde Wang; Kate Gardner; Mickias B Tegegn; Clifton L Dalgard; Camille Alba; Stephan Menzel; Hamel Patel; Mehdi Pirooznia; Yi-Ping Fu; Fayaz T Seifuddin; Swee Lay Thein
Journal:  Blood Adv       Date:  2022-06-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.